China Remains at Risk to Future MonkeyPox Outbreaks.

GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.

GeoVax (GOVX) Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox.

ATLANTA, GA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against...

Mpox Vaccines and ‘Emergency Use’ Authorization Explained.

mpox Vaccine EUAs On November 28, 2022, the World Health Organization announced, and the U.S. government supported, renaming monkeypox disease...

Is There Enough Monkeypox (Mpox) Vaccine to go Around? Maybe yes, More Likely no.

Reported in Gates and Soda As monkeypox cases continue to mount – topping 31,000 cases globally – governments of...

Latest article

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

Mpox Infections Rise to Almost Double Last Year’s Numbers.

The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...